The Serbian Health Insurance Fund (RFZO) and AstraZeneca have signed an agreement in Belgrade to include innovative oncology drugs on the RFZO list for cancer patients.

AstraZeneca announced positive results from a late-stage clinical trial for its Imfinzi regimen, demonstrating a win in the treatment of liver cancer.

AstraZeneca's drug for chronic lung disease has met its primary goals in late-stage trials, demonstrating its ability to reduce flare-ups and leading to a rise in the company's shares, as reported by the Wall Street Journal.

AstraZeneca's stock saw a boost after its new lung drug successfully met its objectives in late-stage clinical trials.

China has given its approval for an innovative breast cancer therapy developed jointly by pharmaceutical companies Daiichi Sankyo and AstraZeneca, expanding treatment options for patients.

AstraZeneca said it would establish drug manufacturing facilities in Guangzhou and Shanghai as well as a separate innovation centre in Shanghai, joining a group of foreign players building new plants…

AstraZeneca’s Imfinzi Gets EU Approval for Treatment of Early Gastric Cancer  WSJ

Abivax stock saw its gains reduced after the company denied speculation regarding a potential deal or collaboration with AstraZeneca.

UK’s GSK is leading the way in research but AstraZeneca is not involved in the area, report finds Business live – latest updates The pipeline of drugs to fight superbugs remains “worryingly thin”…

Currently, many complex conditions can also be treated through minimally invasive procedures, which have become more accessible due to technological advancements.

AstraZeneca boss Pascal Soriot received £17.7 million in pay and bonuses for 2025, with his total compensation increasing by 6.4% due to significant bonuses and share awards.

A fact-checking report clarifies that claims linking the AstraZeneca vaccine to a 'path to death' are false, addressing misinformation surrounding the vaccine.

Deutsche Bank has reiterated its 'Sell' rating on pharmaceutical giant AstraZeneca (AZN) stock. This financial assessment reflects the bank's current outlook on the company's market performance and future prospects.

AstraZeneca's drug for chronic lung disease has met its primary goals in late-stage trials, demonstrating its ability to reduce flare-ups and leading to a rise in the company's shares.

AstraZeneca's experimental drug for chronic obstructive pulmonary disease (COPD) has shown successful outcomes in two Phase 3 clinical trials, leading to a 4% jump in the company's stock.

The Greek Rare Patients Association (ESAE) and AstraZeneca Greece have announced a collaboration aimed at widely disseminating and actively utilizing the Greek Rare Diseases Map (rdgmap.gr).

Guggenheim has increased its price target for pharmaceutical giant AstraZeneca PLC (AZN) from 15,500 GBp to 16,000 GBp, indicating a more optimistic outlook for the company's stock.

Eli Lilly is reportedly considering re-entering the bidding process for Abivax, contingent on whether AstraZeneca fails to meet its acquisition deadline.

Morgan Stanley analysts project double-digit earnings per share (EPS) growth for AstraZeneca PLC (AZN), indicating a positive financial outlook for the pharmaceutical company.

Vor deutschen Gerichten sind Klagen gegen Impfstoffhersteller bisher oft gescheitert. Nun hat eine Zahnärztin aus Mainz vor dem Bundesgerichtshof einen Teilerfolg gegen AstraZeneca errungen.

Xencor's stock has declined following a royalty dispute with AstraZeneca, which led the company to cut its financial guidance.

Increase of 6.4% comes as drugmaker reports strong profit growth, despite cancelling UK investment projects Business live – latest updates Pascal Soriot, the chief executive of Britain’s largest pharmaceutical company, received a 6.4% pay rise last year, taking his total remuneration to £17.7m. The AstraZeneca boss is in line for a further increase this year, potentially making him the UK’s highest-paid chief executive once again. Continue reading...

Hedge funds are identifying Iovance Biotherapeutics Inc. (IOVA) and AstraZeneca PLC (AZN) as leading immunotherapy stocks to buy.

Guggenheim has increased its price target for AstraZeneca PLC (AZN) shares from 16,000 GBp to 16,500 GBp.

Guggenheim has increased its price target for AstraZeneca's stock in anticipation of the company's upcoming first-quarter earnings report.

AstraZeneca's drug for chronic lung disease has met its primary goals in late-stage trials, demonstrating its ability to reduce flare-ups, leading to a rise in the company's shares.

Several stocks, including AstraZeneca, Unity Software, and Coinbase, are experiencing significant movements in premarket trading.

AstraZeneca has announced that its drug Imfinzi has received approval in the European Union for the treatment of early gastric and gastroesophageal cancers.

AstraZeneca’s Imfinzi Gets Expanded EU Label With Approval for Gastric Cancer  WSJ

Σε συνάντησή της με εκπροσώπους του Τύπου, η Πρόεδρος και Διευθύνουσα Σύμβουλος της AstraZeneca Ελλάδας και Κύπρου, Έλενα Χουλιάρα, αναφέρθηκε συνολικά στις δραστηριότητες και τους στόχους της…

Chief executive and chairman of ICI in the 1990s who oversaw the creation of the pharmaceutical company Zeneca Ronnie Hampel was a businessman’s businessman, a major force in the reshaping of ICI, Britain’s largest manufacturing company, in the 1990s and in the birth of the pharmaceutical company Zeneca (now part of AstraZeneca), as well as a powerful influence on other company boards. He was exceptionally well-connected. His place at the heart of the UK business establishment as chairman of...

She receives a Covid vaccination and suffers a sudden hearing loss. Now the woman has brought the legal dispute with the vaccine manufacturer AstraZeneca before the Federal Supreme Court - and achieved partial success.

Agadir – Morocco celebrated International Rare Disease Day with the launch of a new Precision Medicine Hub at the Mohammed VI International University Hospital Complex on Friday in Rabat, a joint project by Fondation Mohammed VI des Sciences et de la Santé (FM6SS) and AstraZeneca.  The Hub aims to improve the diagnosis, treatment, and care […] The post Morocco Establishes National Hub to Advance Rare Disease Treatment appeared first on Morocco World News.

Tempo.co English published a fact-check article debunking the false claim that the name 'AstraZeneca' translates to 'path to death'.